Document:

Exhibit 10.3 Board of Directors Resolutions

Exhibit 10.3

CREATIVE EDGE NUTRITION, INC.

3276 Buford Drive, Bldg. 104, Suite 320, Buford, GA 30519

UNANIMOUS CONSENT OF DIRECTORS OF CREATUVE EDGE NUTRITION, INC. IN LIEU OF A MEETING OF THE BOARD OF DIRECTORS OF CREATIVE EDGE NUTRITION, INC. (A NEVADA CORPORATION)

Pursuant to the Authority granted to directors to take action by unanimous consent without a meeting pursuant to Nevada General Corporation Law 78.315 (pursuant to the Articles of Incorporation) of Creative Edge Nutrition, Inc. (“Creative”) the Board of Directors (“Directors”) of Creative, a Nevada corporation (the “Company”), do hereby consent to adopt, ratify, confirm and approve, as of the date indicated below, the following recitals and resolutions, as evidenced by their signature hereunder:

WHEREAS, the Directors have been presented with the proposal to authorize the issuance of 20,000,000 shares of common stock of the Company in exchange for relief of debt owed by the Company in the amount of Twenty Thousand ($20,000) Dollars represented by a Forty Three Thousand Three Hundred Eighty Four ($43,384) Dollar Promissory Note (the “Promissory Note”) dated May 2, 2012;

WHEREAS, the Directors shall specifically authorize the issuance of 20,000,000 shares of common stock of the Company to First Trust Management;

WHEREAS, the Directors believe it is in the best interest of the Company to authorize the issuance of the common stock to First Trust Management in exchange for relief of the debt represented by the Promissory Note as set forth herein;

NOW, BE IT RESOLVED, that it is hereby authorized and approved to issue 20,000,000 shares of common stock of the Company to First Trust Management in exchange for relief of the debt represented by the Promissory Note.

GENERAL RESOLUTIONS

RESOLVED, that the officers of the Company are hereby authorized and instructed to take whatever steps necessary to effectuate the above described resolutions.

FURTHER RESOLVED, that the Promissory Note shall be restated and amended to show that a payment in the amount of $20,000 on the Promissory Note has been satisfied by the Company.

(Remainder of page intentionally left blank; signature page to follow)

IN WITNESS WHEREOF, the undersigned have set forth their hands in their capacity as of this 2nd day of May, 2012.

/s/ Bill Chaaban                                     

Bill Chaaban, President, CEO, Director

/s/ Reid Stone                                        

REID STONE, Vice President, Director

2Exhibit 10.4 Debt Purchase Agreement

Exhibit 10.4

DEBT PURCHASE AGREEMENT

This Debt Purchase Agreement (“Debt Purchase Agreement”) is made and entered into effective as of May 2, 2012 by and among Gary B. Wolff (“GBW”), First Trust Management, (“FT”) and Creative Edge Nutrition, Inc. (“Creative”).

WHEREAS, the parties to this Debt Purchase Agreement desire to modify that a certain promissory note dated May 2, 2012 (the “Promissory Note”) executed between GBW and Creative by selling, assigning, transferring and conveying the rights and interests to partial payment of the Promissory Note in the amount of Forty Three Thousand Three Hundred Eighty Four ($43,384) Dollars from GBW to FT.

NOW, THEREFORE, for good and valuable consideration, the receipt of which is hereby acknowledged, the parties hereby agree as follows:

1.

Transfer and Assignment. As permitted by Creative, GBW hereby sells, assigns, transfers, and conveys unto FT its rights and interests to receive payments in the amount of $20,000 under the Promissory Note. The remaining rights and interests in the balance of the Debt, if any, will remain with GBW.

2.

Consideration. Consideration to be paid to GBW shall be a total of $20,000.

3.

Agreement to be bound. Creative agrees to be bound by all the terms and conditions applicable to GBW under the Debt.

4.

Entire Agreement. This Debt Purchase Agreement embodies the entire agreement between GBW and FT and supersedes any prior agreements, whether written or oral with respect to the subject matter thereof.

5.

Successors. This Debt Purchase Agreement shall be binding upon and shall inure to the benefit of each of the parties to this Debt Purchase Agreement and each of their respective successors and assigns.

6.

Counterparts. This Debt Purchase Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original as against any party whose signature appears thereon and all of which together shall constitute one instrument.

(Remainder of page intentionally left blank: signature page to follow)

IN WITNESS WHEREOF, the parties hereto have caused this Debt Purchase Agreement to be duly executed and delivered as of the date first written above.

		
	 
	 

	Gary B. Wolff, P.C.

	 

	/s/ Gary B. Wolff

	 

	Name: Gary B. Wolff

	Its: President and Sole Owner

	 

	First Trust Management

	 

	/s/ John Zukowski

	 

	Name: John Zukowski

	 

	 

	ACCEPTED, ACKNOWLEDGED AND APPROVED

	

Creative Edge Nutrition, Inc.

	 

	/s/ Bill Chaaban

	 

	Name: Bill Chaaban

	Its: President, CEO, Director 

2Exhibit 10.20 Subscription Agreement

Exhibit 10.20

May 9, 2012

Health Enhancement Products, Inc.

7 West Square Lake Road

Bloomfield Hills, MI 48302

Attn:  Philip M. Rice II, Chief Financial Officer

Gentlemen:

The undersigned hereby irrevocably and unconditionally subscribes to the acquisition of 2,400,000 (two million, four hundred  thousand) Units of Health Enhancement Products, Inc., a Nevada corporation (the “Company”), each Unit comprised of one share of common stock, $.001 par value (“Common Stock”), of the Company and warrants to purchase one-tenth (1/10) of one shares of Common Stock, at a per Unit price of $.125 (twelve and one half cents).  The aggregate purchase price of the Units is hereunder is $300,000 (three hundred thousand dollars). 

The undersigned irrevocably and unconditionally agrees to purchase and pay for the Units in accordance with the following schedule:  (i) 800,000 Units shall be purchased for $100,000 on the date hereof, (ii) 800,000 Units shall be purchased for $100,000 on or before June 23, 2012 and (iii) an additional 800,000 Units shall be purchased for $100,000 on or before August 7, 2012. The Units and the shares of Common Stock and Warrants underlying the Units are referred to herein as the “Securities.”  

In connection with the purchase of the Securities, the undersigned acknowledges, warrants and represents to and agrees with the Company as follows:

1.

The undersigned is acquiring the Securities for investment for his/her/its own account and without the intention of participating, directly or indirectly, in a distribution of the Securities and not with a view to resale or any distribution of the Securities, or any portion thereof.

2.

The undersigned has such knowledge and experience in financial and business matters that he/she/it is capable of evaluating the merits and risks of this investment.  The undersigned has consulted with his/her/its own professional representative as he/she/it has considered appropriate to assist in evaluating the merits and risks of this investment.  The undersigned has carefully reviewed all of the company’s filings with the Securities and Exchange Commission, including, but not limited to, its Form 10K for the year ended December 31, 2011.  The undersigned has had access to and an opportunity to question the officers of the Company, or persons acting on their behalf, with respect to publicly available material information about the Company, and, in connection with the evaluation of this investment, has, to the best of his/her/its knowledge, received all information and data with respect to the Company that the undersigned has requested and which is necessary to enable the undersigned to make an informed decision regarding the purchase of the Securities.  The undersigned is acquiring the Securities based solely upon his/her/its independent examination and judgment as to the prospects of the Company.  The undersigned acknowledges that there is no minimum or maximum offering amount.  Accordingly, the undersigned acknowledges that once the Company accepts this subscription, the Company may use the funds representing the purchase price of the Securities.

3.

The Securities were not offered to the undersigned by means of publicly disseminated advertisements or sales literature.

4.

The undersigned acknowledges that an investment in the Securities is speculative and involves a high degree of risk and the undersigned may have to continue to bear the economic risk of the investment in the Securities for an indefinite period.  An investment in the Company involves a high degree of risk because, among other reasons, the Company (i) is in the development stage and has no revenue; (ii) is experiencing significant negative cash flow and operating losses; (iii) has a substantial working capital deficiency; and (iv) has a near  term need for substantial additional capital.  The undersigned acknowledges that the foregoing factors raise substantial doubt about the Company’s ability to continue as a going concern as disclosed in the Company’s Form 10K for the year ended December 31, 2011.  The undersigned acknowledges that, as a result of all of the foregoing, among other reasons, there is a significant risk that the undersigned could sustain a total loss of its investment in the Company.

5.

The undersigned acknowledges that the Securities are being sold to the undersigned without registration under any state or federal law requiring the registration of securities for sale, and accordingly, will constitute “restricted securities” as defined in Rule 144 of the U. S. Securities and Exchange Commission.  Consequently, the transferability of the Securities is restricted by applicable United States Federal and state securities laws.  The undersigned understands that the Company’s common stock is currently quoted on the OTC Bulletin Board (in the “over-the-counter” market), and is highly illiquid.

6.

In consideration of the acceptance of this subscription, the undersigned agrees that the Securities will not be offered for sale, sold or transferred by the undersigned other than pursuant to (i) an effective registration under the Securities Act of 1933, as amended (“the Act”), an exemption available under the Act or a transaction that is otherwise in compliance with the Act; and (ii) an effective registration under the securities laws of any state or other jurisdiction applicable to the transaction, an exemption available under such laws, or a transaction that is otherwise in compliance with such laws. 

7.

The undersigned understands that no U. S. federal or state agency has passed upon the offering of the Securities or has made any finding or determination as to the fairness of any investment in the Securities.

8.

The undersigned agrees not to disclose or use any information provided to the undersigned by the Company or any of its agents in connection with the offering of the Securities, except for the purpose of evaluating an investment in the Securities.

9.

The residence address of the undersigned is as set forth below.

10.

The undersigned represents and warrants to the Company that the undersigned is an “Accredited Investor”, as such term is defined on Appendix A hereto.

11.

The undersigned agrees to indemnify and hold harmless the Company and its officers, directors, employees and agents from and against any and all costs, liabilities and expenses (including attorneys’ fees) arising out of or related in any way to any breach of any representation or warranty contained herein.

12.

The Company has the right, in its sole discretion, to accept or reject this subscription.

ACCEPTANCE OF SUBSCRIPTION

SUBSCRIBER

Health Enhancement Products, Inc.

Chris Maggiore

/s/ Chris Maggiore__

Signature

By: /s/ Philip M. Rice, II________________

Residence:  Ohio:

      Philip M. Rice II, Chief Financial Officer

Dated:  May 10, 2012

APPENDIX A

An “Accredited Investor” within the meaning of Regulation D under the Securities Act of 1933 includes the following:

Organizations

(1)

A bank as defined in Section 3(a)(2) of the Act, or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Act, whether acting in its individual or fiduciary capacity; a broker or dealer registered pursuant to section 15 of the Securities Exchange Act of 1934; insurance company as defined in section 2(13) of the Act; an investment company registered under the Investment Company Act of 1940 or a business development company s defined in section 2(a)(48) of that act; a Small Business Investment Company licensed by the U. S. Small Business Administration under section 301(c) or (d) of the Small Business Investment Act of 1958; an employee benefit plan within the meaning of Title I of the Employee Retirement Income Security Act of 1974, if the investment decision is made by a plan fiduciary, as defined in section 3(21) of such act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are accredited investors.

(2)

A private business development company as defined in Section 202(a)(22) of the Investment Advisors Act of 1940.

(3)

A trust (i) with total assets in excess of $5,000,000, (ii) not formed for the specific purpose of acquiring the Securities, (iii) whose purchase is directed by a person who, either alone or with his purchaser representative, has such knowledge and experience in financial and business matters that he is capable of evaluating the merits and risks of the proposed investment.

(4)

A corporation, business trust, partnership, or an organization described in section 501(C)(3) of the Internal Revenue Code, which was not formed for the specific purpose of acquiring the Securities, and which has total assets in excess of $5,000,000.

Individuals

(5)

Individuals with income from all sources for each of the last two full calendar years whose reasonably expected income for this calendar year exceeds either of:

a.

$200,000 individual income; or

b.

$300,000 joint income with spouse

NOTE:

Your “income” for a particular year may be calculated by adding to your adjusted gross income as calculated for Federal income tax purposes any deduction for long term capital gains, any deduction for depletion allowance, any exclusion for tax exempt interest and any losses of a partnership allocated to you as a partner.

(6)

Individuals with net worth as of the date hereof (individually or jointly with your spouse), including the value of home, furnishings and automobiles, in excess of $1,000,000.

(7)

Directors, executive officers or general partners of the Issuer.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}]]